大黄蔗虫丸对大鼠肝星状细胞活化及增殖的影响

目的观察大黄蔗虫丸对大鼠肝星状细胞活化及增殖的影响。方法用链酶蛋白酶和胶原酶原位灌注消化正常大鼠肝脏,Nycodenz密度梯度离心分离肝星状细胞(HSC),在制备大黄蔗虫丸大鼠药物血清的基础上,温育HSC。MTT比色法测定细胞增殖,流式细胞仪检测细胞凋亡及增殖周期情况。结果药物血清对体外培养的HSC有抑制作用,且存在浓度剂量依赖关系,但作用较弱,需在20%以上方见到显著性差异(P<0.05),对HSC凋亡及细胞增殖周期则无显著影响(P>0.05)。结论大黄蔗虫丸对HSC增殖有一定抑制作用,但可能不是其抗肝纤维化作用的主要途径,其抗肝纤维化作用与诱导细胞凋亡无关。     

Prevalence of the cardiovascular health status in adults: A systematic review and meta-analysis

Background and aims

The American Heart Association has outlined seven cardiovascular health (CVH) metrics, including smoking, body mass index, physical activity, dietary pattern, total cholesterol, and fasting plasma glucose, to define and monitor CVH status. Our study was to evaluate the global CVH in adults.

Characterization of the epidermal growth factor receptor in the gastric mucosa

The effects of epidermal growth factor (EGF), a potent mitogen involved in mucosal protection, are mediated by specific cellular receptors. Here, we present the characteristics and binding properties of EGF receptors in the gastric mucosa. The studies were conducted using cell membranes isolated by subcellular fractionation of rat stomach mucosal scrapings. Specific binding of [125I]-EGF to the membrane preparations was assessed at room temperature for various periods of time and at different pHs. The results showed that the binding was proportional to the incubation time up to 1 h and was not affected by a pH change between 4.0 and 7.0. Scatchard analysis of the binding data infer the presence of 2 binding sites, one of high affinity (Kd = 1.34 nM, Bmax = 34 fmol/mg protein) and the other of low affinity (Kd = 484 nM, Bmax = 2.29 pmol/mg protein). Cross-linking experiments using disuccinimidyl suberate to link the [125I]-EGF to gastric membranes followed by polyacrylamide gel electrophoresis and autoradiography revealed that the major receptor for EGF was a protein of 170 kilodaltons. When the solubilized membranes were subjected to wheat germ agglutinin affinity chromatography, the purified material was found to act as substrate for EGF-stimulated phosphorylation. The major component which was labeled by the [gamma-32P]-ATP was also found to be a 170-kilodalton protein. The data are the first to provide evidence that the gastric mucosa possesses a functional EGF receptor and describe its binding characteristics.     

Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo

Glutathione-S-transferases (GSTs) not only show cytoprotective role and their involvement in the development of anticancer drug resistance, but also transmit signals that control cell proliferation and apoptosis. However, the role of GST isoforms in chemotherapy resistance remains elusive in pancreatic cancer. Here, we demonstrated that gemcitabine treatment increased the GSTM2 expression in pancreatic cancer cell lines. Knockdown of GSTM2 by siRNA elevated apoptosis and decreased viability of pancreatic cancer cells treated with gemcitabine. Moreover, in vivo experiments further showed that shRNA induced GSTM2 downregulation enhanced drug sensitivity of gemcitabine in orthotopic pancreatic tumor mice. We also found that GSTM2 levels were lower in tumor tissues than in non-tumor tissues and higher GSTM2 expression was significantly associated with longer overall survival. In conclusion, our findings indicate that GSTM2 expression is essential for the survival of pancreatic cancer cells undergoing gemcitabine treatment and leads to chemo resistance. Downregulation of GSTM2 in pancreatic cancer may benefit gemcitabine treatment. GSTM2 expression in patients also shows significant correlation with overall survival. Thus, our study suggests that GSTM2 is a potential target for chemotherapy optimization and prognostic biomarker of pancreatic cancer.     

Effects of autogenous reinfusion of ascitic fluid on plasma atrial natriuretic peptide and renin activity in cirrhotic patients]

Acute volume loading produced by autogenous reinfusion of ascitic fluid provides an ideal volume expansion model for studying hormonal regulation and it was carried out in 10 cirrhotic patients with massive ascites. The basal plasma ANP level in the cirrhotic patients with ascites was 1776.00 +/- 160.72 ng/L, which was significantly elevated as compared with the level in normal controls (378.36 +/- 39.58 ng/L, P less than 0.01), PRA was significantly higher in patients with ascites (5.13 +/- 0.18 micrograms/l/h) than in healthy volunteers (1.46 +/- 0.31 micrograms/l/h, P less than 0.01). During reinfusion of ascitic fluid there was a significant natriuresis and diuresis; ANP rose from a basal mean value to a peak value of 2166.00 +/- 195.70 ng/l (P less than 0.05) at periinfusion. Subsequently, ANP dropped at 1 hour after infusion (1819.00 +/- 165.92ng/L, P less than 0.05), PRA dropped progressively from a mean basal level to that of 2.48 +/- 0.58 micrograms/l/h (P less than 0.05) at periinfusion. These data demonstrate that there is no evidence for absolute deficiency of ANP in cirrhosis with ascites. The immediate diuresis and natriuresis were associated with a rise in ANP, but the sustained renal consequences may be possibly connected with suppression of RAAS.     

益肝康等活血化瘀中药抑制IL-1β刺激的HSC增殖及TIMP-1的表达

目的:探讨活血化瘀中药益肝康、丹参小复方、丹参对IL-1β刺激的活化的大鼠肝星状细胞(HSCs)增殖及基质金属蛋白酶抑制因子 mRNA(TIMP mRNA)表达的影响．方法:体外培养活化的大鼠HSC,随机分为8 组:对照组(A组)、IL-1β 10 μg/L(B组)、IL- 1β 10μg/L 益肝康2 g/L干预组(C组)、IL- 1β 10 μg/L 丹参小复方2g/L干预组(D组)、 IL-1β 10μg/L 丹参2g/L干预组(E组)、丹参 2 g／L(F组)、丹参小复方2 g/L(G组)、益肝康 2 g／L(H组)．加药后24 h．应用活细胞计数试剂盒-CCK-8检测各组HSC增殖,采用半定量 RT-PCR方法检测各组HSC TIMP-1 mRNA的表达．结果:A组HSC增殖和TIMP-1 mRNA表达强于F、G、H组(1．291±0．09 vs 1．055±0．105, 1±0．07,0．883±0．06,P<0．01:0．591±0．064 vs 0．493±0．088．0．458±0．076．0．356±0．046． P<0．05或P<0．01);H组HSC增殖和TIMP-1 mRNA表达低于F组和G组(P<0．05);B组HSC 增殖和TIMP-1 mRNA表达均明显强于A组 (1．575±0．017 vs 1.291±0,09,P<0．01;1．369± 0．097 vs 0．591±0．064,P<0．01)和C、D、E组 (1．575±0．017 vs 0．906±0．09,1．015±0．081, 1．097±0．038,P<0．01;1．369±0．097 vs 0．694 ±0．078,0．854±0．05,0．898±0．12,P<0．01);C 组HSC增殖和TIMP-1 mRNA表达低于D组和 E组(P<0．05)．结论:益肝康等活血化瘀中药能抑制IL-1β刺激的HSCs增殖及TIMP-1 mRNA表达,发挥其抗肝纤维化功效．益肝康抗肝纤维化作用强于丹参小复方和丹参单药．     

2004～2012年上海市已婚育龄妇女IUD使用率的变化趋势及其影响因素分析

目的:了解上海市已婚育龄妇女宫内节育器(IUD)使用率的变化趋势并分析其影响因素。方法:对2004~2012年上海已婚育龄妇女避孕节育数据进行加权、单因素分析及多因素分析。结果:上海已婚育龄妇女的IUD使用率从2004年的71.3%下降至2012年的43.9%;年龄45岁的妇女IUD使用率是30岁者的2.63倍;初中文化妇女IUD使用率是大学以上妇女的2.15倍。结论:年龄越大、文化水平越低的妇女IUD使用率越高;IUD使用率逐年下降可能与上海近年来加大避孕套宣传和符合生育二孩条件妇女比例增加有关。     

Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea?

Background

Surfactant proteins B and C are mainly synthesized, secreted by alveolar type II cells, and affected by hypoxia and mechanical stretches. We hypothesized that their serum levels might be altered by intermittent hypoxia and swing of intrathoracic pressure of obstructive sleep apnea (OSA).

Methods

Consecutive 140 middle-aged males, suspicious of OSA determined by polysomnography, were studied. Surfactant proteins B and C were determined by ELISA.

Results

Surfactant protein B (41.39?±?6.01 vs 44.73?±?7.62 ng/L, p?=?0.005), not C (32.60?±?6.00 vs 32.43?±?6.44 ng/L, p?=?0.61), significantly lowered in moderate to severe OSA subjects than in non to mild OSA subjects. Severity of OSA is inversely correlated with serum surfactant protein B. Adjusting age, body mass index, and smoking history, compared to subjects with surfactant protein B (SP-B) ≥43.35 ng/L, those with SP-B <43.35 ng/L showed significantly increased 1.528-fold risk for moderate to severe OSA (p?=?0.009), whereas no association between surfactant protein C and OSA was observed. Prevalence of moderate to severe OSA in lower SP-B group is higher than that in higher SP-B group (62.7 vs 38.4 %, p?=?0.003). Serial and parallel tests on Epworth sleep scale (ESS) and SP-B evaluation can be complementary and prove helpful with high specificity (94.44 %) and sensitivity (84.48 %) to detect moderate to severe OSA.

Conclusions

Serum surfactant protein B, rather than C, is decreased in some individuals with moderate to severe OSA, compared to non to mild OSA subjects. Serum surfactant protein B might be a potential biomarker to diagnose OSA.

     

转移性乳腺癌的化疗策略

乳腺癌是女性最常见的恶性肿瘤之一,其发病率高居女性肿瘤疾病首位,全世界每年约有50万妇女死于乳腺癌。晚期乳腺癌的治疗目标是控制疾病、缓解症状、延长患者生存时间、提高患者生存质量、减少治疗相关毒性。本文介绍了晚期乳腺癌化疗的相关指征、不同化疗方案的选择、后续的维持治疗方案在转移性乳腺癌患者中的应用情况。     

成人全麻患者术后早期少量饮水安全性和可行性分析

目的：探讨成人全麻患者术后早期少量饮水的安全性和可行性。方法将200例麻醉后监测治疗室全麻患者按随机数字表法分为观察组和对照组各100例。观察组患者实施麻醉后监测治疗室常规护理的同时给予早期少量饮水;对照组患者实施麻醉后监测治疗室常规护理。分别评价两组患者口干程度变化、复苏满意度、呕吐误吸发生率和再次饮水人数。结果观察组患者口干评分为(7.51±1.48)分,明显高于对照组口干评分(1.39±1.20)分,差异有统计学意义(t=32.12,P<0.05);观察组发生误吸4例,对照组6例,两组比较差异无统计学意义(χ2=0.42,P>0.05);观察组复苏满意度评分为(92.35±2.64)分,明显高于对照组的(67.94±7.46)分,差异有统计学意义( t=30.85,P<0.05);观察组有再次饮水意愿者96例,对照组为91例,两组比较,差异有统计学意义(χ2=2.06,P>0.05)。结论全麻患者术后早期饮水具有安全性和可行性。